CDIO

Cardio Diagnostics Holdings Inc. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website cardiodiagnosticsinc.com
Employees(FY) 7
ISIN US14159C1036

Performance

+0.33%

1W

-29.13%

1M

-58.99%

3M

-27.0%

6M

-70.68%

YTD

-50.68%

1Y

Profile

Cardio Diagnostics Holdings, Inc., an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago, Illinois.

Advanced Technical Analysis

Technical Analysis of CDIO 2024-05-10

Overview:

In analyzing the technical indicators for CDIO stock over the last 5 days, we will delve into the trends, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining key metrics such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim t...

See more ...

Recent News & Updates

2024-05-12 20:31
Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week(Businesswire)
2024-05-06 20:45
New Study Shows Cardio Diagnostics' (NASDAQ: CDIO) PrecisionCHD Test Could Save Health Insurers Over $113 Million Annually(Newsdirect)
2024-04-30 20:30
3 Trends In Healthcare Guided By AI And The Companies Behind The Innovation(Newsdirect)
2024-04-28 20:31
Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD Test Could Save Health Insurers Over $113 Million Annually(Businesswire)
2024-04-23 20:30
As the Use of AI In Healthcare Grows, Cardio Diagnostic Is Using It In Quest to Help Prevent Cardiovascular Disease(Newsdirect)
2024-04-11 20:45
Cardio Diagnostics Inks Groundbreaking Telehealth Agreement With Navierre And Expands Access To Cardiovascular Tests(Newsdirect)
2024-04-08 20:31
Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan(Businesswire)
2024-04-03 20:31
Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre(Businesswire)
2024-03-13 20:31
Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiologys 73rd Annual Scientific Session(Businesswire)
2024-03-04 19:31
Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease(Businesswire)
2024-02-14 19:46
Cardio Diagnostics Holdings, Inc. Expands HeartRisk Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout(Businesswire)
2024-02-06 19:31
Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart Supercenters(Businesswire)
2024-02-04 19:31
Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease Tests(Businesswire)
2024-01-23 19:31
Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor(Businesswire)
2024-01-07 19:31
Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India(Businesswire)
2024-01-03 22:36
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk(Yahoo Finance)
2024-01-03 19:31
Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk(Businesswire)
2024-01-02 19:31
American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event(Businesswire)
2024-01-01 19:31
American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code(Businesswire)
2023-12-20 20:21
Cardio Diagnostics Holdings, Inc. Appoints Biotechnology Investor, Executive & Serial Entrepreneur Paul Burton to its Board of Directors(Businesswire)
2023-12-05 19:31
Cardio Diagnostics Holdings, Inc. Regains Nasdaq Minimum Bid Price Requirement(Businesswire)
2023-12-04 04:38
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare Conference(Yahoo Finance)
2023-12-03 19:31
Cardio Diagnostics Holdings, Incs Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare Conference(Businesswire)
2023-11-27 19:31
American Medical Association is Reviewing Cardio Diagnostics Holdings, Incs Integrated Epigenetic-Genetic Cardiovascular Medicine Tests for CPT PLA Codes(Businesswire)
2023-11-19 20:00
Cardio Diagnostics Establishes A New Partnership To Facilitate Global Footprint And Expansion Beyond North America With India-Based Aimil Ltd.(Yahoo Finance)
2023-11-19 19:31
Cardio Diagnostics Holdings, Inc. Announces Breakthrough in Coronary Heart Disease Detection with PrecisionCHD Test, Published in the Journal of the American Heart Association(Businesswire)
2023-11-13 20:25
With New Lab/Operations Hub, Cardio Diagnostics Says its Prepared To Meet Uptake In Demand, Announces New Partner Initiative(Yahoo Finance)
2023-11-06 20:01
Family Medicine Specialists Selects Cardio Diagnostics Epigenetic-Genetic Tests for Assessing Heart Attack Risk for its BlueCross BlueShield Patients(Businesswire)
2023-10-30 21:15
Cardio Diagnostics Leverages AI To Combat Cardiovascular Disease(Yahoo Finance)
2023-10-30 21:01
Cardio Diagnostics Holdings, Inc Receives Innovative Technology Contract from Vizient for Its Novel AI-Driven Precision Heart Disease Tests Epi+Gen CHD & PrecisionCHD(Businesswire)

Page 1 of 3

previousnext